Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Sialorrhea × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 17 Condylomata Acuminata 3 Carcinoma, Basal Cell 3 Urinary Bladder Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Keratosis 2 Glioblastoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Sialorrhea 1 Sexually Transmitted Diseases 1 Papillomavirus Infections 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Atypical Squamous Cells of the Cervix 1 Adenocarcinoma 1

Interventions

Imiquimod 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡